Management of Premenopausal Women with Early-Stage Breast Cancer: Is There a Role for Ovarian Suppression?
- 1 October 2002
- journal article
- review article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 3 (4) , 260-267
- https://doi.org/10.3816/cbc.2002.n.029
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Ovarian Ablation for Premenopausal Early-Stage Breast Cancer: An UpdateTumori Journal, 2000
- Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation CarriersJNCI Journal of the National Cancer Institute, 1999
- Plasma Sex Steroid Hormone Levels and Risk of Breast Cancer in Postmenopausal WomenJNCI Journal of the National Cancer Institute, 1998
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Ovarian ablation in early breast cancer: overview of the randomised trialsThe Lancet, 1996
- Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screeningBMJ, 1995
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.Journal of Clinical Oncology, 1986
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896